[1] Wu YW,Sullivan J,McDaniel SS,et al.Incidence of Dravet syndrome in a US population[J].Pediatrics,2015,136(5):1310-1315.
[2] Bayat A,Hjalgrim H,Mller RS.The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000:a population-based study from 2004 to 2009[J].Epilepsia,2015,56(4):36-39.
[3] Al-Baradie RS.Dravet syndrome,what is new?[J].Neurosciences,2013,18(1):11-17.
[4] Akiyama M,Kobayashi K,Ohtsuka Y.Dravet syndrome:a genetic epileptic disorder[J].Acta Med Okayama,2012,66(5):369-376.
[5] Baulac S,Gourfinkel-An,Nabbout R,et al.Fever,genes,and epilepsy[J].Lancet Neurol,2004,3(7):421-430.
[6] Lin WD,Chou IC,Tsai FJ.Novel human pathological mutations.Gene symbol:SCN1A.Disease:generalized epilepsy with febrile seizures plus[J].Hum Genet,2010,127(4):478.
[7] Scheffer IE.Diagnosis and long-term course of Dravet syndrome[J].Eur J Paediatr Neurol,2012,16(Suppl 1):5-8.
[8] Guerrini R.Dravet syndrome:the main issues[J].Eur J Paediatr Neurol,2012,16( Suppl 1):1-4.
[9] Lossin C.A catalog of SCN1A variants[J].Brain Dev,2009,31(2):114-130.
[10] Claes L,Ceulemans B,Audenaert D,et al.De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy[J].Hum Mutat,2003,21(6):615-621.
[11] Depienne C,Bouteiller D,Keren B,et al.Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females[J].PLoS Genet,2009,5(2):e1000381.
[12] Harkin LA,Bowser DN,Dibbens LM,et,al.Truncation of the GABA (A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus[J].Am J Hum Genet,2002,70(2):530-536.
[13] Patino GA,Claes LR,Lopez-Santiago LF,et,al.A functional null mutation of SCN1B in a patient with Dravet syndrome[J].J Neurosci,2009,29(34):10764-10778.
[14] Chiron C,Dulac O.The pharmacologic treatment of Dravet syndrome[J].Epilepsia.2011,52(Suppl 2):72-75.
[15] Caraballo RH.Nonpharmacologic treatments of Dravet syndrome:focus on the ketogenic diet[J].Epilepsia,2011,52(Suppl 2):79-82. |